Realizing the Promise of Artificial Intelligence in Pathology
Digital pathology specialist Proscia has been working hard to change the current pathology narrative. The Philadelphia, PA-based company has made several moves to accomplish this goal and its most recent move is a collaboration with the University of California, San Francisco (UCSF).
Proscia builds software and has a platform for imaging workflow management that allows a pathologist in the lab to take digitized images of the glass slides the tissue biopsy sites on and move these images through workflows. The company uses its computational AI-based applications to find patterns in the imaging and transform that information into something meaningful for the pathologist.
However, Proscia doesnât have a laboratory and thatâs where UCSF comes in, said Nathan Buchbinder, the firmâs co-founder and Chief Product Officer. He noted the collaboration with UCSF is essential to Prosciaâs growth as it builds on the companyâs softwareâs deep learning capabilities.
"Building AI takes a lot of data and a lot of focus and research on how changes in that data â how changes in different laboratories impact the performance of artificial intelligence,â Buchbinder told MD+DI. âSo, working with a group like UCSF allows us to not just collect the data but also the variety of information that we need to ensure the AI we build works in practic...
Source: MDDI - Category: Medical Devices Authors: Omar Ford Tags: Digital Health Business Source Type: news
More News: Dermatology | Hospitals | Laboratory Medicine | Learning | Medical Devices | Pathology | Study | Universities & Medical Training